Princeton Alpha Management’s Integra LifeSciences IART Stock Holding History

Princeton Alpha Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,445	Closed	-$524K	–	178
2017 Q1	$524K	Buy	+12,445	New	+$532K	0.18%	188
2016 Q3	–	Sell	-6,990	Closed	-$279K	–	836
2016 Q2	$279K	Buy	+6,990	New	+$251K	0.05%	549
2015 Q4	–	Sell	-12,396	Closed	-$369K	–	803
2015 Q3	$369K	Buy	+12,396	New	+$388K	0.08%	399

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Princeton Alpha Management's IART Position: Q2 2017 in Review

Princeton Alpha Management sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 12,445 shares — an estimated $524K sold.

Princeton Alpha Management first reported a position in IART in Q3 2015 and held it in 3 quarters. The position peaked at $524K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Princeton Alpha Management reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 12,445 Integra LifeSciences shares in Q2 2017, an estimated $524K.
Princeton Alpha Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 3 quarters.
Princeton Alpha Management's Integra LifeSciences position peaked at $524K in Q1 2017.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.